and coordinated by
.
mentioned that a final confirmation/practical arrangements will
be concluded at a next Steering Board meeting.
3. Q&A on AZ contract
The objective of the Q&A session was to give MS an opportunity to ask any remaining questions
on the AZ contract. Clarifications provided at the meeting are noted below.
Timeline of delivery
Post Market monitoring studies
Relationship between APA and the EU Public Procurement Directive
The Public Procurement Directive 2014/24/EC does not apply in the specific case of APA and
APA does not need to be implemented using provisions of the national procurement law. As it is
a procurement at the EU level, it is governed by the provisions of Regulation (EU, Euratom)
2018/1046 (the Financial Regulation) and Council Regulation (EU) 2016/369 on the provision of
emergency support within the Union, as amended by Council Regulation (EU) 2020/521[3]
(Article 4(5)(b) in particular).
Declaration of confidentiality and of absence of conflict of interests
EC confirmed that anyone who has access to the AZ contract or any other confidential
information for the purpose of analysis and decision making process would need to sign the
declaration of confidentiality and of absence of conflict of interests.
Action: EC to circulate the updated declaration of confidentiality and of absence of conflict of
interests. (
done post meeting)
Minimum number of doses
MS have to buy all doses allocated pro rata or opt out from receiving all of them. The pro rata
national allocation cannot be reduced or split into smaller “packages”, however,
MS can buy additional doses if they wish to do so.
5 days opt-out vs National Holidays
Public holidays declared in the EU register will be taken into account and the period for deciding
the opt-out will be extended accordingly